BARTOLONI BOCCI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 11.753
AS - Asia 7.234
EU - Europa 7.180
SA - Sud America 1.494
Continente sconosciuto - Info sul continente non disponibili 788
AF - Africa 205
OC - Oceania 11
Totale 28.665
Nazione #
US - Stati Uniti d'America 11.329
SG - Singapore 3.391
IT - Italia 1.481
IE - Irlanda 1.208
BR - Brasile 1.140
RU - Federazione Russa 1.104
HK - Hong Kong 1.002
CN - Cina 867
FR - Francia 832
VN - Vietnam 769
UA - Ucraina 680
SE - Svezia 577
DE - Germania 372
FI - Finlandia 283
KR - Corea 232
GB - Regno Unito 208
IN - India 199
CA - Canada 191
BD - Bangladesh 170
AR - Argentina 116
IQ - Iraq 73
TR - Turchia 71
MX - Messico 62
NL - Olanda 62
ZA - Sudafrica 62
CO - Colombia 60
AT - Austria 56
EC - Ecuador 55
PL - Polonia 53
CH - Svizzera 51
JP - Giappone 51
ID - Indonesia 50
PK - Pakistan 50
UZ - Uzbekistan 50
VE - Venezuela 45
ES - Italia 42
SA - Arabia Saudita 36
MA - Marocco 32
PH - Filippine 32
CZ - Repubblica Ceca 31
CR - Costa Rica 28
KE - Kenya 28
JM - Giamaica 25
MY - Malesia 25
LB - Libano 23
BE - Belgio 22
TT - Trinidad e Tobago 22
IL - Israele 21
CL - Cile 20
UY - Uruguay 20
NI - Nicaragua 18
EG - Egitto 16
GT - Guatemala 16
LT - Lituania 16
PY - Paraguay 16
TN - Tunisia 15
AE - Emirati Arabi Uniti 13
AL - Albania 13
OM - Oman 13
PE - Perù 13
RO - Romania 13
SV - El Salvador 12
GR - Grecia 11
JO - Giordania 11
KZ - Kazakistan 11
NP - Nepal 11
DZ - Algeria 10
HN - Honduras 10
HU - Ungheria 10
AU - Australia 9
CW - ???statistics.table.value.countryCode.CW??? 9
ET - Etiopia 9
PS - Palestinian Territory 9
PT - Portogallo 8
TH - Thailandia 8
EE - Estonia 7
KG - Kirghizistan 7
PA - Panama 7
PR - Porto Rico 7
AZ - Azerbaigian 6
BB - Barbados 6
BG - Bulgaria 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
GP - Guadalupe 6
RS - Serbia 6
EU - Europa 5
MD - Moldavia 5
SC - Seychelles 5
AO - Angola 4
CY - Cipro 4
KW - Kuwait 4
LV - Lettonia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
LY - Libia 3
MN - Mongolia 3
SI - Slovenia 3
SN - Senegal 3
Totale 27.832
Città #
Singapore 2.297
Dublin 1.201
San Jose 1.157
Chandler 1.138
Hong Kong 995
Ashburn 980
San Mateo 641
Council Bluffs 469
Santa Clara 452
Boardman 415
Dong Ket 390
Moscow 370
Lauterbourg 298
Perugia 296
Medford 283
Princeton 283
Altamura 267
Jacksonville 246
Seoul 230
Lawrence 228
Wilmington 212
Los Angeles 211
Beijing 193
Des Moines 184
Andover 155
New York 148
Ho Chi Minh City 121
Munich 118
The Dalles 115
São Paulo 112
Ann Arbor 109
Hanoi 98
Piscataway 87
Helsinki 86
Saint Petersburg 85
Dallas 73
Norwalk 69
North Bergen 64
San Paolo di Civitate 64
Rome 59
Milan 58
Atlanta 52
Chicago 52
Montreal 49
Phoenix 42
Rio de Janeiro 41
San Francisco 41
Tokyo 38
Brooklyn 37
Falls Church 37
Buffalo 35
Frankfurt am Main 35
Houston 35
Charlotte 34
Denver 34
Johannesburg 34
Nuremberg 34
Tashkent 34
Cambridge 32
Orem 32
Toronto 32
Warsaw 31
Vienna 30
Woodbridge 30
Chennai 29
Baghdad 28
Manchester 28
Shanghai 28
Stockholm 27
Nairobi 25
Naples 25
Belo Horizonte 24
Boston 24
Columbus 23
Mumbai 23
Philadelphia 22
Turku 22
Amsterdam 21
Guayaquil 21
Hefei 21
London 21
Brussels 20
Ottawa 20
Redmond 20
Porto Alegre 19
Redwood City 19
Ribeirão Preto 19
Riverbank 19
Medellín 18
Mexico City 18
Bologna 17
Brasília 17
Da Nang 17
San José 17
Seattle 17
Buenos Aires 16
Caracas 16
Florence 16
Izmir 16
Montevideo 16
Totale 16.657
Nome #
Osteoporosi regionale migrante: un caso clinico con dettagliata documentazione RMN. 300
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies 234
Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment 228
Identificazione della lipocaina come nuovo autoantigene nella sindrome di Sjögren primaria. 163
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis 151
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 141
Ambiente e malattie reumatiche: il fumo. 139
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 136
Sindrome algodistrofica paraneoplastica: case report e possibile approccio terapeutico. 135
Classical and autoimmune factors associated with intima-media thickness in rheumatoid arthritis 131
Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario? 131
Analisi della correlazione tra distensione della capsula articolare ed ipercarico metatarsale in soggetti con metatarsalgia meccanica. 130
Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases. 129
Identification of regulatory T cells in systemic lupus erythematosus 129
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study. 127
Associazione tra anticorpi anti-citrullina ed aterosclerosi subclinica in una coorte di soggetti affetti da artrite reumatoide. 127
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study. 126
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 125
Isolation and characterization of a new human T regulatory cell subset from peripheral blood CD4+ T lymphocyte 123
CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. 122
A Platelet's Guide to Synovitis 122
2023 International Rome consensus for the nomenclature of Sjögren disease 119
AB0037 CD4+CD25-GITR+regulatory T cells are expanded in the blood, display suppressive function and are inversely correlated with disease activity in patients with primary Sjögren’s syndrome 119
Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New 118
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in rheumatoid arthritis patients 118
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature 118
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). 117
Expansion of regulatory GITR+CD25low/-CD4+ T cells in systemic lupus erythematosus patients 115
Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody. 115
A Higher Disease Activity in Anti-Ssa/ssb Positive Sjögren's Syndrome Is Explained by A Higher Clinical and Biological B-Cell Activation: Table 1 114
Microbiota and arthritis: cause or consequence? 113
Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation--a homogeneous, multiplexed system. 113
Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? 113
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 113
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 112
Immunomodulatory effects of human umbelical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) on circulating T-cell subsets in patients with Sjogren's syndrome 111
DETERMINATION OF TRPV1+/T LYMPHOCYTES IN INFLAMMATORY ARTHRITIS AND THEIR CORRELATION WITH ULTRASOUND FINDINGS 111
Policondrite ricorrente e sindrome mieloproliferativa cronica in soggetto con spondilite anchilosante: effetto del trattamento con anti-TNF alpha. 110
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 110
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives 110
Rituximab treatment for persistent scleritis associated with rheumatoid arthritis 109
The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome 109
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 107
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 107
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. 106
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 106
Autoimmune hypophysitis 106
Heat shock protein-60 and -65, and anti-oxidized LDL autoantibodies in Sjogren's syndrome 105
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in Rheumatoid Arthritis 105
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients. 105
Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. 104
Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations. 104
Association Between Glandular Infiltrate and Leukopenia in Sjögren Syndrome (SS): Data From the Italian Research Group on SS (GRISS) 104
Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: A pilot study 104
Circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis. 104
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease Registry 103
Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome. 102
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications. 102
Endothelial Microparticles and Circulating Endothelial Progenitor Cells in Primary SjöGren’s Syndrome Patients: Correlation with Clinical and Immunological Features 102
Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity 102
Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment 102
La sclerosi sitemica progressiva 101
Role of regulatory T cells in rheumatoid arthritis: fact and hypothesis 101
Association between clinical, histopathological and molecular features in primary Sjögren’s Syndrome: a retrospective study 101
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance? 100
L'ipertensione arteriosa polmonare nelle malattie reumatiche 99
“Artrite reumatoide ed altri reumatismi infiammatori cronici: inquadramento attuale” 99
CD4+CD28- lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients 99
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 99
A9.18 Potential Therapeutic Application of Human Umbilical Cord wharton Jelly Derived Mesenchymal Stem Cells in Primary Sjogren's Syndrome 99
Recent views on the pathogenesis of cardiovascular damage associated with rheumatoid arthritis 99
Characterisation of articular manifestations in primary Sjögren's syndrome: clinical and imaging features 99
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 99
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica 98
Quantificazione del DNA circolante nelle malattie reumatiche autoimmuni: ipotesi su una possibile correlazione con l’attività di malattia 98
Acro-osteolysis of the big toe in a patient with psoriatic arthritis. 98
Associazione tra sindrome di Sjögren primaria e malattia celiaca. 98
Rituximab in primary Sjögren's syndrome: a ten-year journey. 98
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide. 98
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 97
Gli Esami di autoimmunologia nella diagnosi e nel monitoraggio della sclerosi sistemica-il quesito del clinico - 21° Congresso Nazionale SIMEL 96
Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. 96
AB0191 Clinical significance of multiple autoantibody specificities in rheumatoid arthritis: the role of anti-citrullinated alpha enolase and anti-interferon inducible protein 16 96
Crescentic glomerulonephritis and circulating antineutrophil cytoplasmic antibodies in scleroderma: a case report and review of the literature 95
Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link 95
GALACTOXYLOMANNAN IS A POWERFUL IMMUNE SYSTEM MODULATOR ABLE TO REBALANCE TREG/TH17 RATIO IN RHEUMATOID ARTHRITIS 95
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 95
A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis 95
Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality? 95
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 95
JAK inhibitors and autoimmune rheumatic diseases 94
Association of subclinical atherosclerosis and leukopenia in systemic autoimmune diseases 94
La sindrome di Sjogren 94
Endothelial microparticles and circulating endothelial progenitor cells in inflammatory rheumatic diseases: effect of anti-inflammatory therapy. 94
IL-17 producing-DN T cells are expanded in the blood, infiltrate salivary glands and are resistant to corticosteroids in sjÖgren’s syndrome 94
Circulating Endothelial Microparticles and Endothelial Progenitors Cells in Primary SjÖGren's Syndrome: New Markers of Chronic Endothelial Damage? 94
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 94
Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis 94
Endothelial microparticles and circulating endothelial progenitor cells in primary Sjögren’s syndrome patients: a potential marker of endothelial damage?. 93
Extra-articular rheumatoid arthritis 93
Totale 11.287
Categoria #
all - tutte 137.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.720 0 0 0 109 101 37 43 690 31 60 269 380
2022/20234.081 308 736 36 304 312 523 8 185 1.493 11 126 39
2023/20241.464 112 174 69 43 22 76 294 38 122 45 226 243
2024/20254.408 75 419 79 158 562 179 95 298 1.083 275 824 361
2025/20268.984 744 539 517 1.112 1.099 722 1.612 582 950 714 211 182
2026/20273.365 204 389 612 2.160 0 0 0 0 0 0 0 0
Totale 28.665